ESPR
XNASESPERION THERAPEUTICS INC
2 news · 90d
2 news · vs previous 7d (—)
Sentiment scores computed by AI · Not investment advice.
Track $ESPR sentiment without checking the page.
Top-discussed tickers and the AI sentiment we read. Not advice.
News · 2
How did the price react? →- SeekingAlpha5/1/2026, 12:46:58 PMEsperion jumps on $1.1 billion ARCHIMED buyout
Esperion Therapeutics is being acquired by European private equity firm ARCHIMED in a deal valued at $1.1 billion. The buyout announcement has driven a sharp jump in Esperion's share price. No additional deal terms or closing timeline were disclosed in the headline.
Sentiment 0.92Relevance 100% - GlobalNewswire5/1/2026, 11:00:00 AMEsperion to be Acquired by ARCHIMED
Esperion Therapeutics has agreed to be acquired by ARCHIMED, with shareholders set to receive $3.16 per share in cash at closing. In addition, shareholders will have the right to participate in up to $100 million in aggregate contingent milestone payments. The deal represents a confirmed M&A transaction for the publicly traded biopharmaceutical company.
Sentiment 0.85Relevance 100%